InsidersTradesSigma
Follow the 甘李药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). The latest transaction was filed on 3 September 2026 (Sale). Among the most active insiders: 李智. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Ganli Pharmaceutical is a company focused on the research and development of drugs, as well as the manufacturing and sale of pharmaceutical products. It is listed on the Shanghai Stock Exchange.